Michaelj Pellini News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Saturday, Zacks.com reports. The firm currently has a $3.75 price objective on the stock. Zacks Investment Research‘s target price suggests a potential upside of 12.28% from the stock’s […]

Singular Genomics Systems (NASDAQ:OMIC – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Friday, Zacks.com reports. According to Zacks, “Singular Genomics Systems Inc. is a life science technology company. It focused on delivering genomic technologies for the advancement of science and medicine. […]